BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30160343)

  • 21. AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis.
    Wang Q; Gao S; Shou Y; Jia Y; Wei Z; Liu Y; Shi J; Miao D; Miao Q; Zhao C; Liu C; Yang H; Xu T; Zhang X
    Int J Biol Sci; 2023; 19(4):1266-1283. PubMed ID: 36923928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIM2 inflammasome contributes to aldosterone-induced renal injury via endoplasmic reticulum stress.
    Wu Y; Yang H; Xu S; Cheng M; Gu J; Zhang W; Liu S; Zhang M
    Clin Sci (Lond); 2022 Jan; 136(1):103-120. PubMed ID: 34935888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathological role of NLRs and AIM2 inflammasome-mediated pyroptosis in damaged blood-brain barrier after traumatic brain injury.
    Ge X; Li W; Huang S; Yin Z; Xu X; Chen F; Kong X; Wang H; Zhang J; Lei P
    Brain Res; 2018 Oct; 1697():10-20. PubMed ID: 29886252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma.
    Wang K; Xu T; Ruan H; Xiao H; Liu J; Song Z; Cao Q; Bao L; Liu D; Wang C; Cheng G; Liang H; Chen Z; Yang H; Chen K; Zhang X
    Cell Death Dis; 2019 Feb; 10(3):159. PubMed ID: 30770793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
    J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of absent in melanoma 2 (AIM2) induces G2/M cell cycle arrest and promotes invasion of colorectal cancer cells.
    Patsos G; Germann A; Gebert J; Dihlmann S
    Int J Cancer; 2010 Apr; 126(8):1838-1849. PubMed ID: 19795419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway.
    Ma X; Guo P; Qiu Y; Mu K; Zhu L; Zhao W; Li T; Han L
    Oncotarget; 2016 Jun; 7(24):36185-36197. PubMed ID: 27167192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lentinan from shiitake selectively attenuates AIM2 and non-canonical inflammasome activation while inducing pro-inflammatory cytokine production.
    Ahn H; Jeon E; Kim JC; Kang SG; Yoon SI; Ko HJ; Kim PH; Lee GS
    Sci Rep; 2017 May; 7(1):1314. PubMed ID: 28465544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
    Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
    Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated.
    Liu S; Xie F; Wang H; Liu Z; Liu X; Sun L; Niu Z
    Oncol Rep; 2015 Mar; 33(3):1372-80. PubMed ID: 25571917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
    Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis.
    Chen SL; Liu LL; Lu SX; Luo RZ; Wang CH; Wang H; Cai SH; Yang X; Xie D; Zhang CZ; Yun JP
    Mol Oncol; 2017 Sep; 11(9):1225-1240. PubMed ID: 28580773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absent in melanoma 2 regulates tumor cell proliferation in glioblastoma multiforme.
    Chen PA; Shrivastava G; Balcom EF; McKenzie BA; Fernandes J; Branton WG; Wheatley BM; Petruk K; van Landeghem FKH; Power C
    J Neurooncol; 2019 Sep; 144(2):265-273. PubMed ID: 31280432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
    Wang LN; Zhu XQ; Song XS; Xu Y
    J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and tumor significance of tropomyosin-1 expression levels in renal cell carcinoma.
    Wang J; Guan J; Lu Z; Jin J; Cai Y; Wang C; Wang F
    Oncol Rep; 2015 Mar; 33(3):1326-34. PubMed ID: 25607530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
    Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
    Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of AIM2 inflammasome activation by a novel transcript isoform of IFI16.
    Wang PH; Ye ZW; Deng JJ; Siu KL; Gao WW; Chaudhary V; Cheng Y; Fung SY; Yuen KS; Ho TH; Chan CP; Zhang Y; Kok KH; Yang W; Chan CP; Jin DY
    EMBO Rep; 2018 Oct; 19(10):. PubMed ID: 30104205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of Tescalcin inhibits growth and metastasis in renal cell carcinoma via downregulating NHE1 and NF-kB signaling.
    Luo AJ; Tan J; He LY; Jiang XZ; Jiang ZQ; Zeng Q; Yao K; Xue J
    Exp Mol Pathol; 2019 Apr; 107():110-117. PubMed ID: 30594602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.